TABLE 2.
Characteristic | Controls | Adenomas | Hyperplastic Polyps | Both | |||
---|---|---|---|---|---|---|---|
N (%) | N (%) | OR (95% CI)* | N (%) | OR (95% CI)* | N (%) | OR (95% CI)* | |
Current BMI (kg/m2)‡ | |||||||
18.5–24.9 | 319 (41%) | 170 (33%) | 1.00 (Referent) | 277 (40%) | 1.00 (Referent) | 68 (30%) | 1.00 (Referent) |
25–29.9 | 293 (38%) | 202 (39%) | 1.21 (0.92–1.58) | 263 (38%) | 1.02 (0.80–1.31) | 82 (36%) | 1.08 (0.74–1.59) |
≥30 | 158 (21%) | 143 (28%) | 1.65 (1.22–2.25) | 148 (22%) | 1.09 (0.81–1.45) | 76 (34%) | 2.15 (1.43–3.22) |
p-trend | 0.002 | 0.6 | 0.0003 | ||||
BMI (kg/m2) age 18‡ | |||||||
<18.5 | 87 (11%) | 62 (12%) | 1.23 (0.86–1.77) | 73 (11%) | 0.95 (0.67–1.35) | 18 (8%) | 0.84 (0.47–1.50) |
18.5–24.9 | 603 (79%) | 377 (73%) | 1.00 (Referent) | 536 (78%) | 1.00 (Referent) | 160 (71%) | 1.00 (Referent) |
25–29.9 | 72 (9%) | 58 (11%) | 1.21 (0.83–1.77) | 69 (10%) | 1.05 (0.73–1.50) | 43 (19%) | 1.99 (1.28–3.09) |
≥30 | 6 (1%) | 16 (3%) | 4.02 (1.55–10.50) | 8 (1%) | 1.35 (0.46–3.97) | 5 (2%) | 3.02 (0.89–10.28) |
p-trend | 0.2 | 0.6 | 0.002 | ||||
Weight Gain from age 18‡ | |||||||
Weight Loss | 51 (7%) | 28 (5%) | 1.03 (0.60–1.78) | 46 (7%) | 1.26 (0.78–2.03) | 10 (4%) | 1.22 (0.54–2.74) |
0–5 kg | 150 (20%) | 80 (16%) | 1.00 (Referent) | 108 (16%) | 1.00 (Referent) | 25 (11%) | 1.00 (Referent) |
6–10 | 124 (16%) | 86 (17%) | 1.23 (0.83–1.82) | 123 (18%) | 1.37 (0.96–1.96) | 32 (14%) | 1.34 (0.74–2.44) |
11–20 | 245 (32%) | 165 (32%) | 1.18 (0.84–1.66) | 229 (33%) | 1.28 (0.94–1.75) | 85 (38%) | 1.90 (1.15–3.14) |
21+ | 196 (26%) | 153 (30%) | 1.41 (0.99–2.02) | 178 (26%) | 1.29 (0.93–1.80) | 73 (32%) | 2.16 (1.28–3.63) |
Physical activity¶ | |||||||
Never | 476 (62%) | 352 (68%) | 1.00 (Referent) | 424 (61%) | 1.00 (Referent) | 152 (67%) | 1.00 (Referent) |
Ever | 296 (38%) | 167 (32%) | 0.78(0.61–1.00) | 267 (39%) | 1.02 (0.81–1.27) | 75 (33%) | 0.88 (0.63–1.24) |
Total minutes of exercise (per week)¶ | |||||||
No exercise | 476 (62%) | 352 (68%) | 1.00 (Referent) | 424 (61%) | 1.00 (Referent) | 152 (67%) | 1.00 (Referent) |
<45 | 67 (9%) | 36 (7%) | 0.73 (0.47–1.13) | 55 (8%) | 0.89 (0.60–1.32) | 18 (8%) | 0.84 (0.47–1.50) |
45–89 | 79 (10%) | 51 (10%) | 0.90 (0.61–1.33) | 78 (11%) | 1.11 (0.78–1.57) | 16 (7%) | 0.64 (0.35–1.19) |
90–119 | 56 (7%) | 26 (5%) | 0.66 (0.40–1.09) | 46 (7%) | 0.94 (0.62–1.44) | 15 (7%) | 1.12 (0.60–2.09) |
≥120 | 94 (12%) | 54 (10%) | 0.79 (0.55–1.15) | 87 (13%) | 1.07 (0.77–1.49) | 26 (11%) | 0.99 (0.60–1.63) |
Adjusted for age, sex, race, education, smoking, alcohol, NSAID use, and family history of colorectal cancer, and menopausal status and hormone use in women
Additional adjusted for physical activity
Additionally adjusted for body mass index and diabetes